Douglas Holtzman, Chief Scientific Officer at Icosavax, Inc. (ICVX), sold 39,296 shares at $11.14 ($438K) on 2022-12-15, disclosed to the SEC on 2022-12-16.
Open-market sale of $438k ICVX by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.14 | 19,648 | $219K | 50.0% |
| 2 | $11.14 | 19,648 | $219K | 50.0% |
| Total | $11.14 avg | 39,296 | $438K | 100% |
| Filing → |
| ICVX | SELL | 2023-02-15 | $50K | — | Filing → |
| ICVX | SELL | 2022-08-02 | $131K | — | Filing → |